Kanae Ichikawa
Overview
Explore the profile of Kanae Ichikawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ichikawa K, Asai T, Shimizu K, Yonezawa S, Urakami T, Miyauchi H, et al.
J Control Release
. 2013 Feb;
167(3):284-9.
PMID: 23419947
A specific antigen-sensitized animal has antigen-specific immune cells that recognize the antigen. Therefore, an antigen-modified drug carrier would be recognized by the immune cells. When such a carrier encapsulates certain...
2.
Siripong P, Yahuafai J, Shimizu K, Ichikawa K, Yonezawa S, Asai T, et al.
Biol Pharm Bull
. 2006 Nov;
29(11):2279-83.
PMID: 17077529
We previously observed that rhinacanthins-C, -N and -Q, three main naphthoquinone esters isolated from the roots of Thai medicinal plant; Rhinacanthus nasutus KURZ. (Acanthaceae) induced apoptosis of human cervical carcinoma...
3.
Siripong P, Yahuafai J, Shimizu K, Ichikawa K, Yonezawa S, Asai T, et al.
Biol Pharm Bull
. 2006 Oct;
29(10):2070-6.
PMID: 17015953
Rhinacanthus nasutus KURZ. (Acanthaceae) has been used as Thai traditional medicine for the treatment of various cancers. Recently, we reported that rhinacanthins, active components of the plant, had antiproliferative activity...
4.
Ichikawa K, Hikita T, Maeda N, Yonezawa S, Takeuchi Y, Asai T, et al.
Biochim Biophys Acta
. 2005 Apr;
1669(1):69-74.
PMID: 15843001
For the improvement of therapeutic efficacy in photodynamic therapy (PDT) by using a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD-MA), we previously prepared polyethylene glycol (PEG)-modified liposomes encapsulating BPD-MA (PEG-Lip...
5.
Takeuchi Y, Ichikawa K, Yonezawa S, Kurohane K, Koishi T, Nango M, et al.
J Control Release
. 2004 Jun;
97(2):231-40.
PMID: 15196750
Previous study indicated that antiangiogenic photodynamic therapy (PDT), laser irradiation at 15 min post-injection of photosensitizer in vivo, is effective for cancer treatment, and a photosensitizer, benzoporphyrin derivative monoacid ring...
6.
Ichikawa K, Takeuchi Y, Yonezawa S, Hikita T, Kurohane K, Namba Y, et al.
Cancer Lett
. 2004 Mar;
205(1):39-48.
PMID: 15036659
We previously observed that antiangiogenic photodynamic therapy (PDT), namely, laser irradiation at 15 min after administration of photosensitizer, by using stable liposomal benzoporphyrin derivative monoacid ring A (BPD-MA), in which...
7.
PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy
Ichikawa K, Hikita T, Maeda N, Takeuchi Y, Namba Y, Oku N
Biol Pharm Bull
. 2004 Mar;
27(3):443-4.
PMID: 14993821
For the purpose of the avoidance of reticuloendothelial system (RES)-trapping, liposome entrapped benzoporphyrin derivative monoacid ring A (BPD-MA), which is used for cancer photodynamic therapy (PDT), was modified with polyethylene...
8.
Takeuchi Y, Kurohane K, Ichikawa K, Yonezawa S, Ori H, Koishi T, et al.
Bioconjug Chem
. 2003 Jul;
14(4):790-6.
PMID: 12862432
To construct a novel drug delivery carrier that possesses high therapeutic efficacy with low dosage, we designed polyethylenimine-modified liposome (polycation liposome, PCL) and examined the entrapment of photosensitizer, benzoporphyrin derivative...
9.
Takeuchi Y, Kurohane K, Ichikawa K, Yonezawa S, Nango M, Oku N
Cancer
. 2003 Apr;
97(8):2027-34.
PMID: 12673734
Background: The authors previously observed that antiangiogenic scheduling of photodynamic therapy (PDT) was effective in causing tumor regression through hemostasis. It would thus be expected that photosensitizer entrapped in polycation...